EUVIMEDEUVIMED entdecken
Fallbericht

Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report

Chia-I Shen, Ju-Chen Chang, Suyog Jain, Steve Olsen, Chiao-En Wu iD

JCO Precision Oncology · 2024

DOI: 10.1200/po.24.00007 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von Chia-I Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Afatinib, Bevacizumab, Carcinoma, Non-Small-Cell Lung, ErbB Receptors. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AfatinibBevacizumabCarcinoma, Non-Small-Cell LungErbB ReceptorsLung NeoplasmsHumansMaleAntineoplastic Combined Chemotherapy ProtocolsMutationAged

Substanzen

AfatinibBevacizumabEGFR protein, humanErbB Receptors

Autor:innen und Institutionen

  • Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.
  • Medical Affairs, Guardant Health AMEA, Singapore.
  • Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.

ORCID-Profile: Chiao-En Wu

Zitieren

APA

Shen, C. I., Chang, J. C., Jain, S., Olsen, S., & Wu, C. E. (2024). Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report. JCO Precision Oncology. https://doi.org/10.1200/po.24.00007

Vancouver

Shen CI, Chang JC, Jain S, Olsen S, Wu CE. Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report. JCO Precision Oncology. 2024. doi:10.1200/po.24.00007

BibTeX
@article{Shen2024,
  author = {Shen, Chia-I and Chang, Ju-Chen and Jain, Suyog and Olsen, Steve and Wu, Chiao-En},
  title = {Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report},
  journal = {JCO Precision Oncology},
  year = {2024},
  doi = {10.1200/po.24.00007}
}
Kostenlos starten →